NAD(P)H:Quinone Oxidoreductase (NQO1) Protects Astroglial Cells Against L-Dopa Toxicity

  • Benjamin Drukarch
  • Cornelis A. M. Jongenelen
  • Freek L. van Muiswinkel
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 500)

Abstract

Astroglial cells are well known to protect neurons against the toxicity of L-Dopa, a catecholaminergic drug used in the treatment of Parkinson’s disease (PD) (Han et al., 1996). This observation, together with the abundance of astroglial cells in the brain, has been used to explain the remarkable absence of overt neurotoxicity of L-Dopa in vivo, as opposed to its clear detrimental effect on neuronal survival in vitro (Agid, 1998). The neurotoxicity of L-Dopa in vitro is thought to be caused primarily by its autooxidative breakdown in the presence of molecular oxygen. Under these circumstances, highly unstable Dopa-quinones are formed which induce neuronal damage mainly as a result of the excessive release of reactive oxygen species (ROS), such as superoxide radicals and hydrogen peroxide, during redoxcycling of these compounds (Bindoli et al., 1992). In contrast to neurons, astroglial cells possess a considerable capacity to detoxify ROS. This feature is thought to form a basis both for their relative resistance to oxidative damage and for their neuroprotective potential (Han et al., 1996; Drukarch et al., 1998). Astroglial ROS scavenging capacity depends to a large extent on the presence of high amounts of the thiol anti-oxidant glutathione in these cells. In fact, neuroprotection against L-Dopa toxicity has been associated with the ability of astroglial cells to increase their glutathione content upon exposure to L-Dopa (Han et al., 1996).

Keywords

Toxicity Dopamine Glutathione Glutamine NADPH 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agid, Y., 1998, Levodopa, is toxicity a myth? Neurology 50: 858–863.PubMedCrossRefGoogle Scholar
  2. Bindoli, A., Rigobello, M. P., and Deeble, D. J., 1992, Biochemical and toxicological properties of the oxidation products of catecholamines, Free Radic. Biol. Med. 13: 391–405.PubMedCrossRefGoogle Scholar
  3. Cadenas, E., 1995, Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism, Biochem. Pharmacol. 49: 127–140.PubMedCrossRefGoogle Scholar
  4. Chen, S., Wu, K., Zhang, D., Sherman, M., Knox, R., and Yang, C. S., 1999, Molecular characterization ofbinding of substrates and inhibitors to DT-diaphorase: combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling, Mol. Pharmacol. 56: 272–278.PubMedGoogle Scholar
  5. Drukarch, B., and van Muiswinkel, F. L., 2000, Drug treatment of Parkinson’s disease: time for phase II, Biochem. Pharmacol. 59: 1023–1031.PubMedCrossRefGoogle Scholar
  6. Drukarch, B., Schepens, E., Stoof, J. C., Langeveld, C. H., and van Muiswinkel, F. L., 1998, Astrocyte enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species, Free, Radic. Biol. Med. 25: 217–220.CrossRefGoogle Scholar
  7. Han, S. K., Mytilineou, C., and Cohen, G., 1996, L-Dopa up-regulates glutathione and protects mesencephalic cultures against oxidative stress., J. Neurochem. 66:501–510.PubMedCrossRefGoogle Scholar
  8. Murphy, T. H., So, A. P., and Vincent, S. R., 1998, Histochemical detection of quinone reductase activity in situ using LY 83583 reduction and oxidation, J. Neurochem. 70: 2156–2164.PubMedCrossRefGoogle Scholar
  9. Schultzberg, M., Segura-Aguilar, J., and Lind, C., 1988, Distribution of DT diaphorase in the rat brain: biochemical and immunohistochemical studies, Neuroscience 27: 763–776.PubMedCrossRefGoogle Scholar
  10. Van Muiswinkel, F. L., Drukarch, B., Steinbusch, H. W. M., and Stoof, J. C., 1993, Chronic dopamine D2 receptor activation does not affect survival and differentiation of cultured dopaminergic neurons: morphological and neurochemical observations, J Neurochem. 60: 83–92.PubMedCrossRefGoogle Scholar
  11. Van Muiswinkel, F. L., Riemers, F. M., Peters, G. J., LaFleur, M. V. M., Siegel, D., Jongenelen, C. A. M., and Drukarch, B., 2000, L-Dopa stimulates expression of the anti-oxidant enzyme NAD(P)H:quinone oxidoreductase (NQO) in cultured astroglial cells, Free Radic. Biol. Med. in press.Google Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Benjamin Drukarch
    • 1
  • Cornelis A. M. Jongenelen
    • 1
  • Freek L. van Muiswinkel
    • 1
  1. 1.Department of NeurologyResearch Institute Neurosciences Vrije UniversiteitAmsterdamThe Netherlands

Personalised recommendations